Navigation Links
Vermillion Reports Third Quarter 2012 Results
Date:11/12/2012

the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.

A replay of the call will be available approximately two hours after the call and until November 26, 2012.

Toll-free replay number: 1-800-633-8284
International replay number: 1-402-977-9140
Replay pin number: 21607929

About OVA1
OVA1 is a blood test for pre-surgical assessment of ovarian tumors for malignancy, using a unique multi-biomarker approach. In a published clinical trial, OVA1 achieved 99% sensitivity in detecting epithelial ovarian cancers (EOC). This included 96% sensitivity for stage I EOC, the earliest and most curable EOC stage, compared with 57% for the conventional biomarker CA125.(1) In addition, OVA1 found 70% of malignancies missed by non-specialist pre-surgical assessment,(1) and it increased detection of malignancy over ACOG guidelines from 77% to 94%.(2) As the first protein-based, In Vitro Diagnostic Multi-Variate Index Assay (IVDMIA) cleared by the FDA, OVA1 also represents a new class of software-based diagnostics.

Citings:
1)
Ueland, FR, et al. Obstet Gynecol 2011:VOL 117, NO. 6, June 2011
2)
Miller R, et al. Obstet Gynecol 2011:VOL 117, NO. 6, June 2011

About Vermillion
Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, vascular medicine and women's health. Additional in
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Vermillion Sets Third Quarter 2012 Conference Call for Monday, November 12, 2012 at 4:30 p.m. ET
2. Vermillion to Present at the 2012 Gateway Conference on September 6
3. Vermillion Reports Second Quarter 2012 Results
4. Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
5. Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions
6. Vermillion Announces CEO Succession Plan
7. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
8. Omeros Corporation Reports Third Quarter 2012 Financial Results
9. VirtualScopics Reports 3rd Quarter 2012 Results
10. Neuland Labs Reports Second Quarter Fiscal Year 2013 Financial Results
11. GenVec Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015 According to ... Product (Moist Heat, Dry Heat, Ethylene Oxide, Filtration, E-beam, Gamma), ... User (Hospitals, Pharmaceuticals) - Global Forecast to 2020", published by ... USD 6.1 Billion by 2020, at a CAGR of 7.6%.from ... market data T ables and ...
(Date:7/31/2015)... LAKE, N.J. and SAN DIEGO ... today that its parent company Eisai Co., Ltd. (Headquarters: ... Haruo Naito , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... CEO: Dr. Helen Torley , "NASDAQ: HALO") have ... mesylate (brand name: Halaven ® , "eribulin") in combination ...
(Date:7/30/2015)... 2015 Mettler-Toledo International Inc. (NYSE: MTD ... below are the highlights: , Sales in ... the prior year. Reported sales decreased 4% as currency ... , Net earnings per diluted share as reported (EPS) ... Adjusted EPS was $2.80 , an increase of ...
Breaking Medicine Technology:Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14
... LONDON, February 23, 2012 A United States federal ... brought by US conglomerate 3M against Harvey Boulter, the CEO of ... on-going global legal dispute. The claims made by 3M ... dismissed. Vindication for Porton Group in New York follows ...
... The management of ReBuilder Medical Technologies, Inc.  (Pink ... complaints with the U.S. Securities Exchange Commission and the ... of the Company shares may have engaged in the ... shares.   The firmed has hired a forensic expert to ...
Cached Medicine Technology:Blackmail Claims Against Harvey Boulter Thrown out of Court 2ReBuilder (RBRM) Files Complaints Against Stock Traders 2
(Date:7/31/2015)... ... July 31, 2015 , ... The 2015 ... patients and family members, medical professionals, and researchers, covering a variety of topics ... is a collaborative effort between the Mesothelioma Applied Research Foundation and Memorial Sloan ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... “HARMONY 2015”, one of the industry’s premier thought leadership symposiums, hosted by ... and 6. The event attracts over 250 “C”-level executives, administrators, directors of ...
(Date:7/31/2015)... ... 31, 2015 , ... The Mount Sinai Health System will work with Columbia ... of related, experimental treatments. The collaboration moves into the next phase with the recent ... of five state licenses to produce and dispense medical marijuana. , Mount Sinai ...
(Date:7/31/2015)... ... 2015 , ... Like nearly every other form of surgery, it shouldn't come ... effective and less intrusive and painful. Leading these advances in the United States ... currently stands as the only doctor in the United States who is qualified to ...
(Date:7/31/2015)... ... July 31, 2015 , ... The Heart Fit Clinic has increased ... until a heart rate of 150 beats versus 100 beats, this is a big ... able to give life back to patients with heart disease," he adds. People with ...
Breaking Medicine News(10 mins):Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2
... Children Learning All Summer Long , ... Salt Lake City, UT (PRWEB) ... the popular Signing Time DVD series and hit public television ... communicate using American Sign Language (ASL) – is pleased to announce the ...
... of the Park Avenue Laser Vision (PALV) Center recently appeared ... a featured guest to discuss the issue of offering his ... the popular video sharing site, YouTube. Dr. Chynn explains ... a way to reach people in their 20s, 30s, and ...
... and soccer players who have had a previous concussion ... of concussion, new research released today at the 2008 ... the JW Marriott Orlando Grande Lakes shows. The study ... for significant differences in test results following the injury. ...
... the only brand,of diabetic socks available anywhere in the ... a Five Year Extended Warranty, has new owners and,is ... ) is pleased,to announce its April 1st 2008 acquisition ... to the UK via the website:, http://www.SmoothToe.co.uk ., ...
... The Pharmaceutical Care,Management Association (PCMA) released the ... which includes a provision that requires,physicians to use ... of an e-prescribing requirement in Medicare is a ... e-prescribing,is the most important issue in the Medicare ...
... Includes Three Provisions That Protect Patient Access ... The U.S. Senate,today voted by unanimous ... Medicare,Improvement for Patients and Providers Act of ... accelerated reimbursements for,Medicare Part D claims, delayed ...
Cached Medicine News:Health News:Two Little Hands Productions Completes the Second Series of Signing Time With Two New DVDs 2Health News:Dr. Emil Chynn Featured on FOX News (WNYW-TV) Park Avenue Laser Vision Center Recognized for Creative Internet Marketing 2Health News:Dr. Emil Chynn Featured on FOX News (WNYW-TV) Park Avenue Laser Vision Center Recognized for Creative Internet Marketing 3Health News:Men and women with history of concussion mend differently, study finds 2Health News:SmoothToe Diabetic Socks Acquired by Lifestyle Medical Group 2
... A C. difficile Rapid Toxin A Test gives ... 10 minutes. When it might be C. difficile, ... that performs only a few tests a day ... for testing, ColorPAC Toxin A C. difficile Rapid ...
... aids should not suffice, then electronic magnification comes ... television set today. With an electronic television reader, ... to 70 times. A video camera shows a ... television monitor. The television reader has been especially ...
... Slit-Lamp. Rechargeable, cordless slit-lamp ... any purpose , Easy selection of ... filter , Extra-bright halogen lamp light ... and extra ,power pack , Supports ...
... Wave combines three advanced technologies - ... easy-to-use refractive diagnostic workstation. Now, with ... refraction, corneal topography, optical path difference ... Wave allows you to evaluate your ...
Medicine Products: